About Vitagene
Vitagene is a company based in San Francisco (United States) founded in 2014 by Reza Malek and Al Hariri. Vitagene has raised $5.8 million across 4 funding rounds from investors including Illumina, BABEL Ventures and Viking Global Investors. The company has 8 employees as of December 31, 2024. Vitagene operates in a competitive market with competitors including Ivenix, Assurex Health, Hygieia, InsightRx and DoseMe, among others.
- Headquarter San Francisco, United States
- Employees 8 as on 31 Dec, 2024
- Founders Reza Malek, Al Hariri
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 1Health.Io Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.8 M (USD)
in 4 rounds
-
Latest Funding Round
$200 K (USD), Seed
Jul 02, 2017
-
Investors
Illumina
& 6 more
-
Employee Count
8
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vitagene
Vitagene has successfully raised a total of $5.8M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vitagene
Vitagene has secured backing from 7 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Illumina, BABEL Ventures and Viking Global Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Investments are directed toward early-stage B2B software and tech companies.
|
Locked | Locked | Locked |
Investor details for Vitagene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vitagene
Investment portfolio details for Vitagene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vitagene
Detailed financials for Vitagene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vitagene Comparisons
Peer comparison for Vitagene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vitagene
Vitagene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ivenix, Assurex Health, Hygieia, InsightRx and DoseMe, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Infusion management systems are developed with wireless web-based architecture.
|
|
| Locked | Locked | Locked |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| Locked | Locked | Locked |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| Locked | Locked | Locked |
Precision dosing is optimized via machine learning and patient data.
|
|
| Locked | Locked | Locked |
Precision dosing tools are provided for healthcare professionals.
|
Detailed competitors of Vitagene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vitagene
Complete news archive for Vitagene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitagene
Vitagene was founded in 2014.
Vitagene is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Vitagene is a funded company, having raised a total of $5.8M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Vitagene is 8.
Vitagene was founded in 2014 in San Francisco, United States, within the health technology sector. A decision support platform is offered to physicians, where algorithms process patient data such as blood work, genetics, and lifestyle details. This data is analyzed using a knowledge base of supplement-disease associations to produce tailored supplement regimens. Operations focus on integrating genomic insights for clinical recommendations.
Vitagene's top competitors include Assurex Health, Ivenix and DoseMe.
Vitagene has 7 investors. Key investors include Illumina, BABEL Ventures, Viking Global Investors, S28 Capital, and Ken Goldman.